Chroma and DPI enter cancer discovery pact.
In: PharmaWatch: Cancer, Jg. 4 (2005-05-01), Heft 5, S. 16-16
report
Zugriff:
Reports that cancer-focused British biotech firm Chroma Therapeutics has entered into collaboration with Discovery Partners International Inc., on the discovery of potential new lead compounds against several selected targets. Terms of the agreement; Comments of the CEO of Chroma Therapeutics, Ian Nicholson regarding on the successful screening against a diverse range of targets; Specializations of Chroma Therapeutics.
Titel: |
Chroma and DPI enter cancer discovery pact.
|
---|---|
Zeitschrift: | PharmaWatch: Cancer, Jg. 4 (2005-05-01), Heft 5, S. 16-16 |
Veröffentlichung: | 2005 |
Medientyp: | report |
Schlagwort: |
|
Sonstiges: |
|